MEDICENNA THERAPEUTICS CORP.

Profile

Company Names

MEDICENNA THERAPEUTICS CORP.

Addresses

2 BLOOR STREET W, SUITE 903, TORONTO, A6 M4W 3E2

2 BLOOR ST W., 7TH FLOOR, TORONTO, A6 M4W 3E2

Phone Numbers

604-671-6673
416 648-5555

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

CANADA (FEDERAL LEVEL)

Total Amount Raised:

$24,022,797.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2026-05-28 
$253,458.00 
$2,343,400.00 
$2,089,942.00 
Equity 
2
2024-04-30 
$14,550,000.00 
$14,587,404.00 
$37,404.00 
Equity 
1
2020-03-17 
$9,219,339.00 
$9,219,339.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALBERT 
 
BERALDO 
DIRECTOR
MEDICENNA THERAPEUTICS CORP.
ALBERT 
G. 
BERALDO 
DIRECTOR
MEDICENNA THERAPEUTICS CORP.
KAREN 
 
DAWES 
DIRECTOR
INSPIRATION BIOPHARMACEUTICALS INC   |  SYMBIOMIX THERAPEUTICS, LLC   |  MEDICENNA THERAPEUTICS CORP.   |  PAXMEDICA, INC.
JOHN 
 
GELTOSKY 
DIRECTOR
MEDICENNA THERAPEUTICS CORP.
ANGELOS 
 
GEORGAKIS 
DIRECTOR
MEDICENNA THERAPEUTICS CORP.
DAVID 
 
HYMAN 
EXECUTIVE OFFICER
MOG INC   |  NETFLIX INC   |  CAMCOR ENERGY FUND VII-B LP   |  ARTIS COFFEE INC.   |  MESENTECH INC.   |  MEDICENNA THERAPEUTICS CORP.   |  PRAIRIE POINTE INVESTORS, L.C.   |  ATTIVO OMAHA INVESTORS LLC
NAGEATTE 
 
IBRAHIM 
EXECUTIVE OFFICER
MEDICENNA THERAPEUTICS CORP.
KARIM 
 
LALJI 
DIRECTOR
MSI METHYLATION SCIENCES, INC.   |  MICROBION CORP   |  MEDICENNA THERAPEUTICS CORP.
FAHAR 
 
MERCHANT 
EXECUTIVE OFFICER, DIRECTOR
PROTOX THERAPEUTICS INC   |  MEDICENNA THERAPEUTICS INC.   |  MEDICENNA THERAPEUTICS CORP.
ROSEMINA 
 
MERCHANT 
EXECUTIVE OFFICER, DIRECTOR
MEDICENNA THERAPEUTICS INC.   |  MEDICENNA THERAPEUTICS CORP.
CHANDRA 
 
PANCHAL 
DIRECTOR
CARDIOGENICS INC.   |  MEDICENNA THERAPEUTICS CORP.
JOHN 
 
SAMPSON 
DIRECTOR
CQS ABS FEEDER FUND LTD   |  GENII INC   |  MEDICENNA THERAPEUTICS CORP.
ANDREW 
 
STRONG 
DIRECTOR
MEDICENNA THERAPEUTICS CORP.   |  K2 BIOLABS, LLC   |  K2 BIOLABS, INC.
RICHARD 
 
SUTIN 
DIRECTOR
MEDICENNA THERAPEUTICS CORP.
ELIZABETH 
 
WILLIAMS 
EXECUTIVE OFFICER
LOVE NEVER DIES LONDON L.P.   |  IMMUCELL CORP /DE/   |  DATE ME OFF BROADWAY LTD LIABILITY CO   |  MEDICENNA THERAPEUTICS CORP.   |  TRIUMVIRA IMMUNOLOGICS INC.   |  INNVENTURE, INC.   |  SATELLOS BIOSCIENCE INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-07-06
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-05-28 
2024-05-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-04-30 
2020-04-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-17 
2020-03-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
HAYWOOD SECURITIES INC.
NONE
HAYWOOD SECURITIES (USA) INC.
849696
MACKIE RESEARCH CAPITAL CORPORATION
NONE
MACKIE RESEARCH USA INC.
39670